At a glance
- Originator Aventis
- Class Antifungals; Immunotherapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 29 Nov 1995 Discontinued-Preclinical for Mycoses in Germany (Unknown route)